T. Rowe Price Associates’s Amphastar Pharmaceuticals AMPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.28M | Sell |
273,288
-267,933
| -50% | -$6.15M | ﹤0.01% | 1220 |
|
|
2025
Q1 | $15.7M | Sell |
541,221
-25,435
| -4% | -$737K | ﹤0.01% | 1007 |
|
|
2024
Q4 | $21M | Sell |
566,656
-2,238
| -0.4% | -$83.1K | ﹤0.01% | 985 |
|
|
2024
Q3 | $27.6M | Sell |
568,894
-15,012
| -3% | -$729K | ﹤0.01% | 921 |
|
|
2024
Q2 | $23.4M | Sell |
583,906
-638
| -0.1% | -$25.5K | ﹤0.01% | 917 |
|
|
2024
Q1 | $25.7M | Sell |
584,544
-2,413
| -0.4% | -$106K | ﹤0.01% | 916 |
|
|
2023
Q4 | $36.3M | Buy |
586,957
+17,245
| +3% | +$1.07M | ﹤0.01% | 787 |
|
|
2023
Q3 | $26.2M | Buy |
569,712
+63,404
| +13% | +$2.92M | ﹤0.01% | 852 |
|
|
2023
Q2 | $29.1M | Buy |
506,308
+37,888
| +8% | +$2.18M | ﹤0.01% | 838 |
|
|
2023
Q1 | $17.6M | Sell |
468,420
-320,750
| -41% | -$12M | ﹤0.01% | 947 |
|
|
2022
Q4 | $22.1M | Sell |
789,170
-19,561
| -2% | -$548K | ﹤0.01% | 884 |
|
|
2022
Q3 | $22.7M | Buy |
808,731
+645,917
| +397% | +$18.2M | ﹤0.01% | 869 |
|
|
2022
Q2 | $5.66M | Buy |
+162,814
| New | +$5.66M | ﹤0.01% | 1404 |
|